CJC-1295 with DAC (10mg)

Pharmaceutical-grade research peptide, lyophilized for stability. Each batch is independently tested and COA-verified with ≥99% purity by HPLC analysis. Intended exclusively for research purposes.

CJC-1295 with DAC is studied as a long-acting GHRH analogue designed to stimulate the GH/IGF-1 axis. Scientific studies focus on GH pulsatility, IGF-1 response, pharmacokinetics and endocrine effects. Human studies have investigated how single administration can influence GH pulses and IGF-1 levels over multiple days. The available data primarily supports a research role within endocrinology and growth hormone physiology.

For laboratory research use only. This information describes areas of scientific investigation and does not constitute medical advice, dosing guidance or therapeutic claims.